Therapeutic Radionuclides to Cure Cancer on the Anvil
Researchers at the Bhabha Atomic Research Centre (BARC) revealed that they are developing a number of therapeutic radionuclides
Researchers at the Bhabha Atomic Research Centre (BARC) revealed that they are developing a number of therapeutic radionuclides which can be used in curing skin and liver tumors.
Lead researcher Dr Meera Venkatesh, who is the head of Radio pharmaceuticals Division at BARC, said that they have identified three radionuclides including Lutetium-177 (Lu-177), Yittrium-90 (Y-90) and Phosphorus-32 (P-32) which can also be used to treat rheumatic arthritis.
"A research carried out in BARC in collaboration with few hospitals in the country has shown Lutetium-177 (Lu-177), Yittrium-90 (Y-90) and Phosphorus-32 (P-32) as very effective therapeutic radionuclides (radio pharmaceuticals) that can be used in the treatment of cancers of liver, skin and in non-cancerous maladies such as rheumatic arthritis and hemophilia", she said.
Source: Medindia